PDEX - NASDAQ
Pro-Dex, Inc.
$66.88
-1.2%Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
At a Glance
Live Snapshotpdex
Total Liabilities and Equity
Last Annual Value
61.19M
3-Year CAGR
8%
5-Year CAGR
14%
10-Year CAGR
17%
Pro-Dex, Inc. Competitors Analysis of Total Liabilities and Equity
| Company | Total Liabilities and Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Pro-Dex, Inc. NASDAQ:PDEX | 61.19M | 5.7% | 4.5% | 18.6% | |
 Assertio Holdings, Inc. NASDAQ:ASRT | 266.97M | -2.3% | -3.9% | -14.1% | |
 Vivani Medical, Inc. NASDAQ:VANI | 39.39M | -4.9% | 48.5% | 8.9% | |
 Fortress Biotech, Inc. NASDAQ:FBIO | 185.55M | 3.5% | -14.1% | 0.8% | |
 MindWalk Holdings Corp. NASDAQ:HYFT | 44.44M | -17.0% | -7.9% | 41.5% | |
 Immunic, Inc. NASDAQ:IMUX | 24.05M | -23.8% | -29.6% | -9.3% | |
 Nutriband Inc. NASDAQ:NTRB | 7.47M | -0.2% | -10.1% | 69.7% | |
 Microbot Medical Inc. NASDAQ:MBOT | 81.54M | 113.9% | 37.2% | 37.5% | |
 Rapid Micro Biosystems, Inc. NASDAQ:RPID | 74.85M | -19.5% | -20.9% | N/A | |
 Sharps Technology, Inc. NASDAQ:STSS | 269.08M | 183.7% | 114.7% | N/A | |
 Apyx Medical Corporation NASDAQ:APYX | 66.84M | -5.5% | -0.6% | 6.6% |
Pro-Dex, Inc. Fair Value Envelope
Related Guides
Continue your PDEX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.